Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Dyskinesia, Drug-Induced

indazoles has been researched along with Dyskinesia, Drug-Induced in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's8 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
da Silva, CA; de Aguiar, D; de Oliveira-Tavares, D; Del Bel, E; Ferreira, NR; Padovan-Neto, FE; Raisman-Vozari, R1
Anselmo-Franci, J; da-Silva, CA; Del-Bel, E; Guimaraes, FS; Padovan-Neto, FE; Raisman-Vozari, R; Romano-Dutra, AC; Szawka, RE1
Anselmo-Franci, J; Carolino, RO; Cavalcanti-Kiwiatkoviski, R; Del Bel, E; Padovan-Neto, FE1
Del-Bel, EA; Espadas, I; Moratalla, R; Solís, O1
Bortolanza, M; Cavalcanti-Kiwiatkoski, R; da-Silva, CA; Del-Bel, E; Mitkovski, M; Padovan-Neto, FE; Raisman-Vozari, R1
Bariotto-Dos-Santos, KD; Bortolanza, M; da-Silva, CA; Del-Bel, E; Dos-Santos-Pereira, M1
Del-Bel, EA; Echeverry, MB; Padovan-Neto, FE; Tumas, V1
da-Silva, CA; Del Bel, EA; Novaretti, N; Padovan-Neto, FE; Tumas, V1
Ago, Y; Hiramatsu, N; Matsuda, T; Ota, Y; Takahashi, T; Takuma, K; Tanaka, T1
Araki, T; Imai, Y; Itoyama, Y; Matsubara, M; Mizugaki, M; Mizutani, H1

Other Studies

10 other study(ies) available for indazoles and Dyskinesia, Drug-Induced

ArticleYear
Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.
    Neuroscience letters, 2013, Apr-29, Volume: 541

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Indazoles; Levodopa; Male; Microinjections; Motor Activity; Nitric Oxide Synthase Type I; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar

2013
Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.
    Neurotoxicity research, 2014, Volume: 25, Issue:1

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Nitric Oxide Synthase; Oxidopamine; Rats; Rats, Wistar; Substantia Nigra

2014
Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats.
    Neuropharmacology, 2015, Volume: 89

    Topics: Animals; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Nitric Oxide Synthase Type I; Oxidopamine; Rats; Rats, Wistar

2015
Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
    Neurobiology of disease, 2015, Volume: 73

    Topics: Animals; Antiparkinson Agents; Benserazide; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Gene Expression Regulation; Homeodomain Proteins; Indazoles; Levodopa; Mice; Mice, Knockout; Molsidomine; Nitric Oxide Donors; Parkinson Disease; Signal Transduction; Time Factors; Transcription Factors

2015
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
    Neurobiology of disease, 2015, Volume: 73

    Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Indazoles; Inflammation; Levodopa; Male; Neuroglia; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease; Rats; Rats, Wistar; Up-Regulation

2015
Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson's Disease.
    Neurotoxicity research, 2016, Volume: 30, Issue:1

    Topics: Amantadine; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Indazoles; Levodopa; Male; Medial Forebrain Bundle; Microinjections; Nitroprusside; Oxidopamine; Parkinson Disease; Rats

2016
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
    Neuroscience, 2009, Mar-31, Volume: 159, Issue:3

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Motor Activity; Nitric Oxide Synthase; Nitroarginine; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra

2009
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2010, Volume: 43, Issue:11

    Topics: Animals; Anti-Dyskinesia Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Nitric Oxide Synthase; Rats; Rats, Wistar; Substantia Nigra

2010
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.
    European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3

    Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Neostriatum; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Parkinsonian Disorders; Protein Subunits; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Signal Transduction

2012
Nitric oxide synthase inhibitors cause motor deficits in mice.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001, Volume: 11, Issue:2

    Topics: Animals; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Haloperidol; Indazoles; Male; Mice; Motor Activity; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I

2001